Document Detail


Immunotherapy with CTL peptide and VSSP eradicated established human papillomavirus (HPV) type 16 E7-expressing tumors.
MedLine Citation:
PMID:  16112257     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Peptide-based vaccines aimed at the induction of effective T-cell responses against established tumors have not been successful in clinic and require the use of new adjuvants. One of those is a new adjuvant in which gangliosides are incorporated into the outer membrane protein complex of Neisseria meningitidis to form very small size proteoliposomes (VSSP). In a preclinical model of human papillomavirus HPV16-induced cervical cancer we show that vaccination with HPV 16 E7 derived minimal CTL peptide and VSSP protects mice against tumor challenge, induces regression of established tumors and produces E7-specific CD8+ T-cell responses.
Authors:
Isis Torréns; Osmany Mendoza; Aileen Batte; Osvaldo Reyes; Luis E Fernández; Circe Mesa; Gerardo Guillén
Related Documents :
8912827 - Lymphoepithelial carcinoma of the larynx and hypopharynx: study of eight cases with rel...
25293717 - Somatic neurofibromatosis type 1 (nf1) inactivation events in cutaneous neurofibromas o...
18087217 - Expression of immune-related molecules in primary ebv-positive chinese nasopharyngeal c...
20939427 - Effects of cidofovir on human papillomavirus-positive cervical cancer cells xenografts ...
21415657 - Unexpected tumor incidence in surgically removed unilateral and bilateral nasal polyps.
18298897 - Establishment and characteristics of two syngeneic human osteosarcoma cell lines from p...
Publication Detail:
Type:  Journal Article     Date:  2005-08-08
Journal Detail:
Title:  Vaccine     Volume:  23     ISSN:  0264-410X     ISO Abbreviation:  Vaccine     Publication Date:  2005 Dec 
Date Detail:
Created Date:  2005-11-28     Completed Date:  2006-03-02     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8406899     Medline TA:  Vaccine     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  5768-74     Citation Subset:  IM    
Affiliation:
Department of Cancer, Center for Genetic Engineering and Biotechnology, P.O. Box 6162, Havana, Cuba.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adjuvants, Immunologic / administration & dosage
Animals
Cell Line
Humans
Immunotherapy
Mice
Mice, Inbred BALB C
Papillomaviridae / drug effects*,  immunology
Papillomavirus Infections / immunology,  therapy*
Peptide Fragments / administration & dosage,  immunology*
Proteolipids / administration & dosage*,  immunology
Tumor Virus Infections / immunology,  therapy*
Vaccines, Subunit / administration & dosage,  immunology
Chemical
Reg. No./Substance:
0/Adjuvants, Immunologic; 0/Peptide Fragments; 0/Proteolipids; 0/Vaccines, Subunit; 0/proteoliposomes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Virulence-associated protein-specific serum immunoglobulin G-isotype expression in young foals prote...
Next Document:  Towards a vaccine for attaching/effacing Escherichia coli: a LEE encoded regulator (ler) mutant of r...